Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects

Clinical trial NCT00615212 · COMPLETED

Trial details

NCT number: NCT00615212
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2008-01-02
Primary completion: 2008-02-15
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.